—
C+
C+ The full Closelook — membership. Open the C+ overview

Abbott Laboratories (ABT) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Abbott Laboratories

ABT in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Abbott Laboratories operates across four segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices. It makes generic drugs, diagnostic testing systems for laboratories and point-of-care settings, infant and adult nutrition products, and devices for cardiovascular disease, diabetes monitoring and neuromodulation. It is based in Abbott Park, Illinois, and sells across international markets.
Where it sits in the stack
Abbott holds no seat in Rubin, our index for the AI build-out; it sits instead in the diary's Healthcare sleeve, under medical devices, alongside diagnostics and pharmaceutical manufacturers.
Who it is priced against
The diary's peer group does not name a comparison set for Abbott; the market often compares it with Johnson & Johnson.
Why Closelook tracks it
Abbott holds a seat in the S&P 500 but not in our own Rubin index, and it does not yet carry a Closelook score. The diary has quoted it once, in a Strategy piece on covered calls across dividend aristocrats, grouping it among slow-compounding healthcare names.
What the diary watches
The diary watches whether Abbott's diagnostics and device segments keep offsetting each other as pandemic-era testing demand normalises.

Abbott Laboratories (ABT) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: ABT news on the tape · index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for ABT, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against ABT on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Dividends and capital return trailing yield 2.43%, quarterly · last 0.63 USD on 2026-07-15

Dividends and capital return

What ABT pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.48 USD per share · a 2.43% yield on the 2026-09-17 close 4 distributions, paid quarterly 2026-09-17
  • Change on the year +6.6% against the prior twelve months prior twelve months 2.33 USD per share
  • Last distribution 0.63 USD per share as the price series records it, within days of the ex-date 2026-07-15
  • By calendar year 2023: 0.51 USD (partial) · 2024: 2.21 USD · 2025: 2.36 USD · 2026: 1.89 USD to date first distribution recorded in the three-year window: 2023-10-12

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Abbott Laboratories (ABT)?

Abbott Laboratories trades as ABT on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is ABT in a Closelook index?

Not currently — Abbott Laboratories is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does ABT trade against its moving averages?

Mixed moving-average stack: Trades -3.4% vs the 50-day and -2.5% vs the 200-day average, 24.5% below the 52-week high and +24.7% off the 52-week low; a golden cross printed 4 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Abbott Laboratories do?

Abbott Laboratories operates across four segments: established pharmaceutical products, diagnostic products, nutritional products, and medical devices. It makes generic drugs, diagnostic testing systems for laboratories and point-of-care settings, infant and adult nutrition products, and devices for cardiovascular disease, diabetes monitoring and neuromodulation. It is based in Abbott Park, Illinois, and sells across international markets. The diary's peer group does not name a comparison set for Abbott; the market often compares it with Johnson & Johnson.

Where does Abbott Laboratories sit in the AI build-out?

Abbott holds no seat in Rubin, our index for the AI build-out; it sits instead in the diary's Healthcare sleeve, under medical devices, alongside diagnostics and pharmaceutical manufacturers. Abbott holds a seat in the S&P 500 but not in our own Rubin index, and it does not yet carry a Closelook score. The diary has quoted it once, in a Strategy piece on covered calls across dividend aristocrats, grouping it among slow-compounding healthcare names.

Does Abbott Laboratories pay a dividend?

Abbott Laboratories has paid 2.48 USD per share over the last twelve months, paid quarterly, a trailing yield of 2.43% on the 2026-09-17 close; the last distribution recorded in the price series was 0.63 USD on 2026-07-15. The "Dividends and capital return" block on this page carries the lines.

Where has Closelook written about Abbott Laboratories?

Abbott Laboratories appears in 1 Closelook piece, most recently Strategy: Covered Calls for Income — the Dividend Aristocrats Approach (2026-05-22). What Closelook said most recently: The list overlaps heavily with the consumer-staples / industrials / healthcare slow-compounders: KO, PG, JNJ, KMB, MMM, ED, ABT, MMC, EMR, ITW, and on. (Strategy, 2026-05-22). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for ABT, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 1 piece · newest: Strategy, “Covered Calls for Income — the Dividend Aristocrats Approach” (2026-05-22)

Mentioned on Closelook

Where ABT appears in the diary — 1 piece, newest first. Every link is our own writing.

Long reads

Related in the Closelook universe

then Medical Devices. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.